The activation of MasR increases NO production through the phosphoinositide 3-kinase (PI3K)/Akt/eNOS pathway and activates SHP-2 in endothelial cells, which counteracts AngII/AT1R-induced hypertension and VEC dysfunction [25]. This evidence concerns the gene MAS1L and Hypertension.